Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoinette Lemoine

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
Frontiers in Oncology|January 8, 2015
Mitochondrial Proteins (e.g., VDAC, Bcl-2, HK, ANT) as Major Control Points in OncologyCatherine Brenner, Antoinette Lemoine
Neuropsychobiology|August 5, 2004
Should major depression with 'high normal' thyroid-stimulating hormone be treated preferentially with tricyclics?Emmanuelle Corruble, Ivan Berlin, Antoinette Lemoine, et al.
Annals of Translational Medicine|April 6, 2016
Mutations at the splice sites of exon 14 of MET gene: a new target for sarcomatoid carcinomas?Marie Wislez, Charlotte Domblides, Alexis Cortot, et al.
The International Journal of Biochemistry & Cell Biology|March 31, 2015
Human enhancer of filamentation 1-induced colorectal cancer cell migration: Role of serine phosphorylation and interaction with the breast cancer anti-estrogen resistance 3 proteinRama Ibrahim, Antoinette Lemoine, Jacques Bertoglio, et al.
International Review of Cell and Molecular Biology|April 27, 2020
Redox signaling in the pathogenesis of human disease and the regulatory role of autophagyShazib Pervaiz, Gregory L Bellot, Antoinette Lemoine, et al.
Gastroenterology|September 6, 2006
Prognostic value of KIT exon 11 deletions in GISTsJean-François Emile, Séverine Tabone-Eglinger, Nathalie Théou-Anton, et al.
Current Pharmaceutical Biotechnology|November 30, 2011
Non-alcoholic steatohepatitis: new insights from OMICS studiesCecile Martel, Davide Degli Esposti, Antonin Bouchet, et al.
Clinical Chemistry and Laboratory Medicine|July 20, 2007
New perspectives and strategy research biomarkers for hepatocellular carcinomaRaphaël Saffroy, Patrick Pham, Maâmar Reffas, et al.
Current HIV Research|March 12, 2009
Relationship between polymerase gamma (POLG) polymorphisms and antiretroviral therapy-induced lipodystrophy in HIV-1 infected patients: a case-control studyFranck Chiappini, Elina Teicher, Raphaël Saffroy, et al.
Cellular Oncology (Dordrecht, Netherlands)|January 6, 2026
The epigenetic regulator SETDB1 as a key component of cancer stem cells and drug resistance in primary liver cancerMaël Padelli, Christophe Desterke, Aurore Devocelle, et al.
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
Frontiers in Oncology|January 8, 2015
Mitochondrial Proteins (e.g., VDAC, Bcl-2, HK, ANT) as Major Control Points in OncologyCatherine Brenner, Antoinette Lemoine
Neuropsychobiology|August 5, 2004
Should major depression with 'high normal' thyroid-stimulating hormone be treated preferentially with tricyclics?Emmanuelle Corruble, Ivan Berlin, Antoinette Lemoine, et al.
Annals of Translational Medicine|April 6, 2016
Mutations at the splice sites of exon 14 of MET gene: a new target for sarcomatoid carcinomas?Marie Wislez, Charlotte Domblides, Alexis Cortot, et al.
The International Journal of Biochemistry & Cell Biology|March 31, 2015
Human enhancer of filamentation 1-induced colorectal cancer cell migration: Role of serine phosphorylation and interaction with the breast cancer anti-estrogen resistance 3 proteinRama Ibrahim, Antoinette Lemoine, Jacques Bertoglio, et al.
International Review of Cell and Molecular Biology|April 27, 2020
Redox signaling in the pathogenesis of human disease and the regulatory role of autophagyShazib Pervaiz, Gregory L Bellot, Antoinette Lemoine, et al.
Gastroenterology|September 6, 2006
Prognostic value of KIT exon 11 deletions in GISTsJean-François Emile, Séverine Tabone-Eglinger, Nathalie Théou-Anton, et al.
Current Pharmaceutical Biotechnology|November 30, 2011
Non-alcoholic steatohepatitis: new insights from OMICS studiesCecile Martel, Davide Degli Esposti, Antonin Bouchet, et al.
Clinical Chemistry and Laboratory Medicine|July 20, 2007
New perspectives and strategy research biomarkers for hepatocellular carcinomaRaphaël Saffroy, Patrick Pham, Maâmar Reffas, et al.
Current HIV Research|March 12, 2009
Relationship between polymerase gamma (POLG) polymorphisms and antiretroviral therapy-induced lipodystrophy in HIV-1 infected patients: a case-control studyFranck Chiappini, Elina Teicher, Raphaël Saffroy, et al.
Cellular Oncology (Dordrecht, Netherlands)|January 6, 2026
The epigenetic regulator SETDB1 as a key component of cancer stem cells and drug resistance in primary liver cancerMaël Padelli, Christophe Desterke, Aurore Devocelle, et al.
Pageof 10